Is a Vote on Depomed Takeover on the Horizon?

Horizon Pharma (HZNP) isn’t ready to walk away from its $1.98 billion hostile takeover bid for fellow drug maker Depomed (DEPO). Horizon is pressuring the maker of pain medication to let shareholders vote on the latest bid, which Depomed rejected last week. Depomed’s bylaws allow shareholders with a stake of 10% or larger to call [...]
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.